Bharat Immunological & Biological Corporation Ltd

BSE
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

Start SIP in Bharat Immunological & Biological Corporation Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
32.72% Fall from 52W High
-24.7
TTM PE Ratio
Negative PE TTM
-6.9
Price to Book Ratio
Below industry Median
1.5
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is less than 1
0.1
RSI
RSI is mid-range
43.1
MFI
MFI is mid-range
54.2

Bharat Immunological & Biological Corporation Ltd shareholding Pattern

Promoter
59.2%
Public
40.7%
Promoter
59.2%
Public
40.8%
Promoter
59.2%
Public
40.8%
Promoter
59.2%
Public
40.7%
Promoter
59.2%
Public
40.7%
Promoter
59.2%
Public
40.8%

Bharat Immunological & Biological Corporation Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
2
Bearish Moving Averages
14
5Day EMA
30.20
10Day EMA
30.60
12Day EMA
30.70
20Day EMA
30.80
26Day EMA
30.80
50Day EMA
31.00
100Day EMA
30.70
200Day EMA
29.30
5Day SMA
30.20
10Day SMA
31.20
20Day SMA
30.90
30Day SMA
30.70
50Day SMA
30.80
100Day SMA
32.20
150Day SMA
29.70
200Day SMA
28.20
Delivery & Volume
Resistance & Support
29.64
Pivot
Resistance
First Resistance
30.47
Second Resistance
31.24
Third Resistance
32.07
Support
First Support
28.87
Second support
28.04
Third Support
27.27
Relative Strength Index
43.06
Money Flow Index
54.15
MACD
-0.15
MACD Signal
0.01
Average True Range
1.68
Average Directional Index
16.68
Rate of Change (21)
-8.89
Rate of Change (125)
25.15
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Alpa Laboratories Ltd.
191.74
55.1
115
Panacea Biotec Ltd.
840.05
113.55
202.2
Vivo Bio Tech Ltd.
-
-
-
Bharat Immunological & Biologicals Corporation Ltd.
-
-
-
Genomic Valley Biotech Ltd.
-
-
-
Shree Ganesh Bio-Tech (India) Ltd.
-
-
-
Advanced Enzyme Technologies Ltd.
4390.77
264
425.1

Bharat Immunological & Biological Corporation Ltd Company background

Founded in: 1989
Managing director: Sanjay Kumar Mishra
The Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Central Public Sector Unit, under the Department of Biotechnology, Ministry of Science and Technology. BIBCOL was incorporated in 1989. The Company is engaged in the manufacture of Oral Polio Vaccine (OPV) , Zinc Tablets and Diarehha management Kit and BIB Sweet Tablets.The companys manufacturing unit is located in Bulandshahr Dist., Uttar Pradesh. BIBCL installed a plant of 100 mln units. Commercial production of the OPV started from Jan96.The company has received firm orders for supply of OPV from the Ministry of Health and Family Welfare, Government of India, for use in the national immunisation programme. It has set up an RD unit for the development of hepatitis B vaccine through transfer of technology from the US.In year 2006, the facility was up graded to meet the WHO cGMP revised schedule M of Drugs Cosmetics Act. In 2016, BIBCOL switched over to bOPV from tOPV . To add in product line, company diversified into Plasma derived medicines, and Oral Cholera Vaccine.
Read More

Bharat Immunological & Biological Corporation Ltd FAQs

You can easily buy Bharat Immunological & Biological Corporation Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage